Connect with us
deals book
Advertisement
Polaris bank
Advertisement
Oando
Advertisement
Alpha
Advertisement
Hotflex
Advertisement
Binance
Advertisement
Advertisement
UBA
Advertisement
Patricia
Advertisement
Access bank
Advertisement
app

Spotlight Stories

Laycon wins Big Brother Naija, to go home with N85 million worth of prizes

Laycon wins N85 million worth of prizes from Big Brother Naija, Season 5.

Published

on

Laycon wins Big Brother Naija, to go home with N85 million worth of prizes

Laycon has emerged winner of the Big Brother Naija Lockdown Season.

The talented rapper/singer beat 19 other housemates to win the coveted N85million worth of prizes after spending 71 days in the Big Brother house and entertaining millions of viewers across Africa.

Laycon and four other housemates – Vee, Neo, Nengi and Dora, after series of evictions made it to the final week of the season’s reality show.

READ: Multichoice may have raked in N5.1 billion from voting on Big Brother Naija

Getting into the house as the 19th housemate and initially assumed as an underdog in the first two weeks, the 26-year-old UNILAG undergraduate came to be admired by fellow housemates and a lot of viewers, including top celebrities for his intelligence, humility and philosophical quotes.

Weeks into the show, the young man became the first housemate in the current season to be verified on Twitter and Instagram, and also the first-ever housemate to gain over a million followers on Instagram while in the house.

Winning tonight makes Laycon the 5th winner of the reality TV show since its inception.

READ: Africa may lose $4.8 billion in crop exports due to Coronavirus

Hotflex

N85 million worth of prizes

  • For winning the show, Laycon will be rewarded with
  • N30million cash prize; an SUV from Innoson Motors;
  • a two-bedroom apartment courtesy of Revolution Plus;
  • a trip to Dublin, Ireland, courtesy of Guinness Nigeria Plc;
  • amazing home appliances courtesy of Scanfrost and other mouthwatering prizes.

Explore Economic and Financial Data on the Nairametrics Research Website

 

This is how the viewers voted:

1 Comment

1 Comment

    Leave a Reply

    Your email address will not be published.

    This site uses Akismet to reduce spam. Learn how your comment data is processed.

    Coronavirus

    Covid-19: WHO approves China’s Sinopharm vaccine

    WHO has announced the approval of China’s Sinopharm vaccine for Covid-19 vaccination.

    Published

    on

    Covid-19: First world nations oppose waiving intellectual rights for vaccine development

    The World Health Organization (WHO) has announced the approval of China’s Sinopharm vaccine for Covid-19 vaccination.  The vaccine is reported to have 79% efficacy against covid.

    This was disclosed today in a report by Reuters. The vaccine would also be the second Chinese-made vaccine after Sinovac vaccine and would be the first developed outside Europe and North America to receive WHO accreditation.

    “This expands the list of COVID-19 vaccines that COVAX can buy, and gives countries confidence to expedite their own regulatory approval, and to import and administer a vaccine,” WHO Director-General, Tedros Adhanom Ghebreyesus said.

    The WHO added that the easy storage requirements make it highly suitable for low-resource settings.

    “Its easy storage requirements make it highly suitable for low-resource settings,” a WHO statement said while also disclosing that the vaccine has been approved for people above the age of 18 to receive two shots.

    “On the basis of all available evidence, WHO recommends the vaccine for adults 18 years and older, in a two-dose schedule with a spacing of three to four weeks,” the statement added.

    The vaccine was created by Beijing Biological Products Institute, a subsidiary of Sinopharm subsidiary China National Biotec Group, with an efficacy of 79% for all age groups.

    The WHO however, admitted that few older adults (over 60 years) were enrolled in clinical trials, so efficacy could not be estimated in this age group.

    Hotflex

    In case you missed it

    The quest for vaccine efficiency got a major boost earlier this week as Nairametrics reported that the United States government announced that it supports the waiver of Intellectual Property Protections on Covid-19 vaccine development, in a bid to boost the fight against the pandemic, and says it will participate in the Okonjo-Iweala-led WTO negotiation to make it happen.

    Continue Reading

    Obituaries

    “Mama Taraba”, Former minister and senator, Aisha Al-Hassan is dead

    Ex-Women Affairs minister, Aisha Jummai Al-Hassan, popularly known as Mama Taraba is dead

    Published

    on

    A former Minister for Women Affairs and ex-Governorship Candidate in Taraba State, Aisha Jummai Al-Hassan, popularly known as Mama Taraba is dead.

    According to media reports she died in a hospital on Friday in Cairo, Egypt at the age of 61.

    Al-Hassan, who was a former senator of the Federal Republic of Nigeria from Taraba North Senatorial District, was the All Progressive Congress (APC) Governorship Candidate for Taraba in the 2015 general elections.

    READ: Abba Kyari’s last letter to President Buhari

    She later contested for the same seat on the platform of the United Democratic Party in the 2019 general elections after resigning from APC and as a minister in the administration of President Muhammadu Buhari on July 27, 2018.

    The former senator was born on the 16th of September, 1959 in Jalingo, Taraba State, to Alhaji Abubakar Ibrahim, Sarkin Ayukan Muri.

    READ: Chad’s President Deby dies of injuries suffered on the frontlines, as son takes over

    Aisha Jummai Al-Hassan attended Muhammed Nya Primary School, Jalingo and LEA Primary School, Tudun Wada, Kaduna before proceeding to Saint Faith College (now GGSS) Kawo Kaduna where she studied between January 1973 and June 1977.

    Hotflex

    Details later…

    Continue Reading

      





    Nairametrics | Company Earnings

    Access our Live Feed portal for the latest company earnings as they drop.